Beta Bionics, Inc.
BBNX
$10.58
-$0.38-3.47%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | |||
|---|---|---|---|---|---|
| Net Income | -18.11M | -- | -18.85M | ||
| Total Depreciation and Amortization | 529.00K | -- | 544.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 6.54M | -- | 12.52M | ||
| Change in Net Operating Assets | -3.24M | -- | -566.00K | ||
| Cash from Operations | -14.28M | -- | -6.35M | ||
| Capital Expenditure | -561.00K | -- | -313.00K | ||
| Sale of Property, Plant, and Equipment | 0.00 | -- | 0.00 | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -29.10M | -- | -69.30M | ||
| Cash from Investing | -29.66M | -- | -69.61M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 38.00K | -- | 9.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | 59.66M | -- | 0.00 | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -2.81M | -- | -- | ||
| Cash from Financing | 56.89M | -- | 9.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 12.95M | -- | -75.95M | ||